We next investigated whether hepatic PLIN2 deficiency could alter the onset or severity of comorbidities associated with NAFLD including obesity, insulin resistance and dyslipidemia. The gene discussed is PLIN2; the disease is metabolic dysfunction-associated steatotic liver disease.